Challenging Drug Patents to Lower Prices
The FTC cracks down on improperly listed drug patents, challenging over 100 patent listings.
Expanding Presidential Influence on Agency Adjudication
The Supreme Court’s decision in U.S. v. Arthrex expands the avenues for politicizing agency adjudication.
Headless Agency Adjudication at the Patent Office
Supreme Court approval of patent adjudication raises new questions about limits of modern agency adjudication.
The First Amendment Protects Offensive Trademarks
Supreme Court holds that government cannot discriminate against offensive trademarks.
Why Federal Courts Should Defer to the PTO in Trademark Disputes
Legal scholar makes the case for courts deferring to agency’s trademark determinations.
Improving Patent Quality by Reducing the Patent Office’s Backlog of Applications
Improving the patent system depends on reducing processing snarls.
Evaluating the PTO’s Proposed Fee Structure
Proposed fee structure remains flawed and may contribute to the perception of a “broken” patent system.